IS8326A - Blandan af serótónín endurupptöku hindra og loxapíni - Google Patents

Blandan af serótónín endurupptöku hindra og loxapíni

Info

Publication number
IS8326A
IS8326A IS8326A IS8326A IS8326A IS 8326 A IS8326 A IS 8326A IS 8326 A IS8326 A IS 8326A IS 8326 A IS8326 A IS 8326A IS 8326 A IS8326 A IS 8326A
Authority
IS
Iceland
Prior art keywords
loxapine
mixture
serotonin reuptake
reuptake inhibitor
inhibitor
Prior art date
Application number
IS8326A
Other languages
English (en)
Inventor
Ivo Franciscus Hubert Cremers Thomas
Hogg Willigers Sandra
Arnt Jørn
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2004/000581 external-priority patent/WO2005023243A1/en
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS8326A publication Critical patent/IS8326A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8326A 2003-09-04 2006-02-23 Blandan af serótónín endurupptöku hindra og loxapíni IS8326A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301270 2003-09-04
PCT/DK2004/000581 WO2005023243A1 (en) 2003-09-04 2004-09-01 The combination of a serotonin reuptake inhibitor and loxapine

Publications (1)

Publication Number Publication Date
IS8326A true IS8326A (is) 2006-02-23

Family

ID=58707235

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8326A IS8326A (is) 2003-09-04 2006-02-23 Blandan af serótónín endurupptöku hindra og loxapíni

Country Status (7)

Country Link
US (1) US20070042014A1 (is)
KR (1) KR20060072127A (is)
CN (1) CN1845730A (is)
EA (1) EA200600531A1 (is)
IL (1) IL173968A0 (is)
IS (1) IS8326A (is)
ZA (1) ZA200601459B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5460594B2 (ja) * 2007-08-03 2014-04-02 リチュテル・ゲデオン・ヴェジェーセティ・ジャール・ニュイルヴァーノシャン・ミューコェデー・レースヴェーニュタールシャシャーグ ドーパミン受容体リガンドを含有する医薬組成物およびドーパミン受容体リガンドを用いる処置方法
WO2012054815A1 (en) 2010-10-22 2012-04-26 Duke University Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies
CN107556206A (zh) * 2016-06-30 2018-01-09 陕西合成药业股份有限公司 一种新型5‑羟色胺再摄取抑制剂类化合物及其制备方法和在医学上的应用
MX2021003203A (es) * 2018-09-21 2021-05-27 Sk Biopharmaceuticals Co Ltd Compuesto de carbamato y uso de la formulacion que comprende el mismo en prevenir, aliviar, o tratar trastorno de estres agudo o trastorno de estres post-traumatico.

Also Published As

Publication number Publication date
US20070042014A1 (en) 2007-02-22
KR20060072127A (ko) 2006-06-27
IL173968A0 (en) 2006-07-05
CN1845730A (zh) 2006-10-11
EA200600531A1 (ru) 2006-08-25
ZA200601459B (en) 2007-05-30

Similar Documents

Publication Publication Date Title
IS7662A (is) Ný þríhringlaga spírópíperídín eða spírópýrrólídín
DK1499311T3 (da) Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer
IS2880B (is) Nýir kínasatálmar
NO20051281D0 (no) Sammensetning for anrikning av naeringsmidler
IL172965A0 (en) The combination of a serotonin reuptake inhibitors and agomelatine
FR2875872B1 (fr) Entrainement
DK1829874T3 (da) Tricyklisk forbindelse og anvendelse deraf
FI20030261A (fi) Iskulaite
FI20031004A0 (fi) Uusi syötävä koostumus
IS8326A (is) Blandan af serótónín endurupptöku hindra og loxapíni
NO20055582D0 (no) Preparater og fremgangsmater omfattende gastrinforbindelser
DE502004000456D1 (de) Ventilsteuerung
SE0300181L (sv) Simuleringsförfarande
DE602004023341D1 (de) Chronograph
FR2843451B1 (fr) Fronde du type lance-pierres
FR2849936B1 (fr) Boulier educatif
DE602004016680D1 (de) N von tests
IS8299A (is) Blanda af serótónín endurupptöku hindra og amoxapíni
IL174069A0 (en) The combination of a serotonin reuptake inhibitor and amoxapine
EE00358U1 (et) Meetod trenazööri kasutamiseks
UA6393S (uk) Рогалик одеський
IS7557A (is) Blönduð meðferð þar sem notaður er serótónín endurupptöku lati
UA9994S (uk) Заготовка ключа
UA9216S (uk) Комплект патерлиць і хреста
FI6132U1 (fi) Puukappaleiden liitos